Filing Details
- Accession Number:
- 0001437749-21-009187
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-19 07:49:12
- Reporting Period:
- 2021-04-16
- Accepted Time:
- 2021-04-19 07:49:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
946486 | Windtree Therapeutics Inc | WINT | Biological Products, (No Disgnostic Substances) (2836) | 943171943 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1716213 | P. John Hamill | 2600 Kelly Road Suite 100 Warrington PA 18976 | Svp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-04-16 | 1,000 | $2.07 | 3,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The shares were purchased in multiple trades at prices ranging from $2.065 to $2.0685. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.